DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Cabergoline (Cabergoline) - Side Effect Reports to FDA

 
 



This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Cabergoline and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.

Reports by Event Outcome

All Cases (130)
Death (6)
Life Threatening Events (5)
Disability (8)

Reports by Reaction Type

Pneumocephalus (11)Neoplasm Progression (9)Visual Pathway Disorder (9)Drug Interaction (8)Headache (6)Pathological Gambling (6)Psychiatric Symptom (6)Visual Field Defect (6)Drug Ineffective (5)Hypersexuality (5)Prolactinoma (5)Tachyphylaxis (5)

Below are a few examples of reports where side effects / adverse reactions may be related to Cabergoline. For a complete list or a specific selection of reports, please use the links above.

Possible Cabergoline side effects in 70 year old female

Reported by a physician from Japan on 2012-08-27

Patient: 70 year old female, weighing 53.5 kg (117.7 pounds)

Reactions: Coronary Artery Disease

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Blinded Therapy
    Dosage: double blind (5mg or placebo) (1 in 1 d)
    Administration route: Oral
    Start date: 2011-10-20

Blinded Therapy
    Dosage: double blind (3mg or placebo) (1 in 1 d)
    Administration route: Oral
    Indication: Parkinson's Disease
    Start date: 2011-10-12
    End date: 2011-10-19

Brotizolam
    Dosage: 0.25 mg, 1x/day
    Administration route: Oral
    Indication: Insomnia
    Start date: 2011-04-14

Cabergoline
    Dosage: 0.5 mg, 1x/day
    Administration route: Oral
    Indication: Parkinson's Disease

Carbidopa
    Dosage: unk
    Administration route: Oral
    Indication: Parkinson's Disease
    Start date: 2007-07-10

Clonazepam
    Dosage: 1 mg, 1x/day
    Administration route: Oral
    Indication: Insomnia
    Start date: 2007-01-01

Comtan
    Dosage: 100 mg, 3x/day
    Administration route: Oral
    Indication: Parkinson's Disease
    Start date: 2009-06-15

Famotidine
    Dosage: 20 mg, 1x/day
    Administration route: Oral
    Indication: Prophylaxis
    Start date: 2011-05-06

Flurbiprofen
    Dosage: unk
    Administration route: Oral
    Indication: Parkinson's Disease
    Start date: 2008-06-19

Gasmotin
    Dosage: 5 mg, 2x/day
    Administration route: Oral
    Indication: Prophylaxis

Magmitt
    Dosage: 1650 mg, 3x/day
    Administration route: Oral
    Indication: Constipation
    Start date: 2007-01-01

Symmetrel
    Dosage: 50 mg, 2x/day
    Administration route: Oral
    Indication: Parkinson's Disease
    Start date: 2009-12-21

Tizanidine Hydrochloride
    Dosage: 1 mg, 3x/day
    Administration route: Oral
    Indication: Parkinson's Disease
    Start date: 2007-12-20

Other drugs received by patient: Digoxin



Possible Cabergoline side effects in 70 year old female

Reported by a physician from Japan on 2012-08-15

Patient: 70 year old female, weighing 53.5 kg (117.7 pounds)

Reactions: Coronary Artery Disease

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Blinded Therapy
    Dosage: blinded therapy
    Administration route: Oral
    Start date: 2011-10-20

Blinded Therapy
    Dosage: blinded therapy
    Administration route: Oral
    Indication: Parkinson's Disease
    Start date: 2011-10-12
    End date: 2011-10-19

Brotizolam
    Dosage: 0.25 mg, 1x/day
    Administration route: Oral
    Start date: 2011-04-14

Cabergoline
    Dosage: 0.5 mg, 1x/day
    Administration route: Oral

Carbidopa
    Dosage: unk
    Administration route: Oral
    Start date: 2007-07-10

Clonazepam
    Dosage: 1 mg, 1x/day
    Administration route: Oral
    Start date: 2007-01-01

Comtan
    Dosage: 100 mg, 3x/day
    Administration route: Oral
    Start date: 2009-06-15

Famotidine
    Dosage: 20 mg, 1x/day
    Administration route: Oral
    Start date: 2011-05-06

Flurbiprofen
    Dosage: unk
    Administration route: Oral
    Start date: 2008-06-19

Gasmotin
    Dosage: 5 mg, 2x/day
    Administration route: Oral

Magmitt
    Dosage: 1650 mg, 3x/day
    Administration route: Oral
    Start date: 2007-01-01

Symmetrel
    Dosage: 50 mg, 2x/day
    Administration route: Oral
    Start date: 2009-12-21

Tizanidine Hydrochloride
    Dosage: unk
    Administration route: Oral
    Start date: 2007-12-20

Other drugs received by patient: Digoxin



Possible Cabergoline side effects in 65 year old male

Reported by a physician from Italy on 2012-08-14

Patient: 65 year old male

Reactions: ON and Off Phenomenon, Drug Effect Decreased, Chorea, Dependence, Pathological Gambling

Drug(s) suspected as cause:
Cabergoline
    Dosage: 8 mg, daily
    Indication: Parkinson's Disease

Carbidopa + Levodopa
    Dosage: 400/100 mg/d
    Indication: Parkinson's Disease

Entacapone
    Dosage: 800 mg, daily
    Indication: Parkinson's Disease

Finasteride
    Dosage: 5 mg, daily
    Indication: Benign Prostatic Hyperplasia

Pramipexole Dihydrochloride
    Dosage: 3.05 mg, daily
    Indication: Parkinson's Disease



Possible Cabergoline side effects in 35 year old female

Reported by a consumer/non-health professional from Colombia on 2012-08-13

Patient: 35 year old female

Reactions: Vomiting, Nausea, Drug Ineffective, Brain Oedema, Dizziness, Headache

Drug(s) suspected as cause:
Cabergoline
    Dosage: 0.5 mg, unk
    Indication: Blood Prolactin Increased
    Start date: 2008-01-01

Dostinex
    Dosage: 4 tablets of 0.5 mg inter-day
    Administration route: Oral

Dostinex
    Dosage: 2 tablets of 0.5 mg inter-day
    Administration route: Oral
    Indication: Blood Prolactin Increased
    Start date: 2008-01-01

Other drugs received by patient: Estrogens; Calcium



Possible Cabergoline side effects in 27 year old female

Reported by a physician from United States on 2012-08-09

Patient: 27 year old female

Reactions: Pneumocephalus

Drug(s) suspected as cause:
Cabergoline



Possible Cabergoline side effects in 68 year old female

Reported by a physician from Japan on 2012-08-09

Patient: 68 year old female, weighing 42.2 kg (92.8 pounds)

Reactions: Back Pain, Secondary Adrenocortical Insufficiency, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cabergoline
    Dosage: 0.25 mg, weekly
    Administration route: Oral
    Start date: 2011-03-10
    End date: 2011-03-22

Cabergoline
    Dosage: 0.5 mg, weekly
    Administration route: Oral
    Start date: 2011-03-23
    End date: 2011-04-05

Cabergoline
    Dosage: 0.75 mg, weekly
    Administration route: Oral
    Start date: 2011-04-06
    End date: 2011-04-29

Cabergoline
    Dosage: 2 mg, weekly
    Administration route: Oral
    Start date: 2011-06-08
    End date: 2011-08-03

Cabergoline
    Dosage: 1 mg, weekly
    Administration route: Oral
    Start date: 2011-04-20
    End date: 2011-05-10

Cabergoline
    Dosage: 1.5 mg, weekly
    Administration route: Oral
    Start date: 2011-05-11
    End date: 2011-06-07



Possible Cabergoline side effects in

Reported by a physician from United States on 2012-08-07

Patient:

Reactions: Pathological Gambling, Compulsive Shopping

Drug(s) suspected as cause:
Cabergoline
    Dosage: 8 mg, / day
    Indication: Product Used FOR Unknown Indication

Carbidopa + Levodopa
    Dosage: 100/400 mg, / day
    Indication: Product Used FOR Unknown Indication



Possible Cabergoline side effects in 30 year old female

Reported by a health professional (non-physician/pharmacist) from Poland on 2012-07-27

Patient: 30 year old female

Reactions: Galactorrhoea, Menstrual Disorder, Prolactinoma, Drug Interaction, Neoplasm Progression

Drug(s) suspected as cause:
Cabergoline
    Dosage: 0.25 mg, twice weekly

Cabergoline
    Dosage: 2 mg, twice weekly

Other drugs received by patient possibly interacting with the suspect drug:
Bromocriptine Mesylate
    Dosage: 20 mg, daily

Bromocriptine Mesylate
    Dosage: 7.5 mg, daily

Bromocriptine Mesylate
    Dosage: 15 mg, daily

Oxcarbazepine
    Dosage: 600 mg daily
    Indication: Convulsion

Oxcarbazepine
    Dosage: 1200 mg daily

Other drugs received by patient: Quinagolide; Quinagolide



Possible Cabergoline side effects in 30 year old female

Reported by a health professional (non-physician/pharmacist) from Poland on 2012-07-27

Patient: 30 year old female

Reactions: Menstrual Disorder, Galactorrhoea, Prolactinoma, Neoplasm Progression, Drug Interaction

Drug(s) suspected as cause:
Cabergoline
    Dosage: 2 mg, twice weekly

Cabergoline
    Dosage: 0.25 mg, twice weekly

Other drugs received by patient possibly interacting with the suspect drug:
Bromocriptine Mesylate
    Dosage: 15 mg, daily

Bromocriptine Mesylate
    Dosage: 7.5 mg, daily

Bromocriptine Mesylate
    Dosage: 20 mg, daily

Oxcarbazepine
    Dosage: 600 mg daily
    Indication: Convulsion

Oxcarbazepine
    Dosage: 1200 mg daily

Other drugs received by patient: Quinagolide; Quinagolide



Possible Cabergoline side effects in 65 year old male

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-07-24

Patient: 65 year old male

Reactions: Irritability, Pathological Gambling, Compulsive Shopping

Drug(s) suspected as cause:
Benserazide, Levodopa
    Dosage: 1000 mg/day
    Indication: Parkinson's Disease

Cabergoline
    Dosage: 8 mg, per day
    Indication: Parkinson's Disease

Carbidopa and Levodopa
    Indication: Parkinson's Disease

Pramipexole Dihychloride
    Dosage: 1.2 mg, per day

Pramipexole Dihychloride
    Dosage: 3.05 mg/day
    Indication: Parkinson's Disease

Other drugs received by patient: Entacapone



Possible Cabergoline side effects in 53 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-19

Patient: 53 year old male

Reactions: Blepharospasm, Psychiatric Symptom, Atrioventricular Block Complete

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Alprazolam
    Dosage: 0.4 mg, 2 in 1 d
    Administration route: Oral
    Indication: Anxiety Disorder

Cabergoline
    Dosage: 1 mg, 1 in 1 d
    Administration route: Oral
    Indication: Parkinson's Disease
    End date: 2012-06-19

Carbidopa
    Dosage: 87.5 mg, 6 in 1 d
    Administration route: Oral
    Indication: Parkinson's Disease
    Start date: 2011-07-20

Comtan
    Dosage: 100 mg, 1 in 1 d
    Administration route: Oral
    Indication: Parkinson's Disease

Donepezil HCL
    Dosage: 5 mg, 1 in 1 d
    Administration route: Oral
    Start date: 2011-07-05
    End date: 2012-06-21

Donepezil HCL
    Dosage: blinded therapy (3mg or placebo) (1 in 1 d)
    Administration route: Oral
    Indication: Parkinson's Disease
    Start date: 2011-06-23
    End date: 2011-07-04

Pramipexole Dihydrochloride
    Dosage: 1 mg, 2 in 1 d
    Administration route: Oral
    Indication: Parkinson's Disease

Pramipexole Dihydrochloride
    Dosage: 0.25 mg, 1 in 1 d
    Administration route: Oral
    Start date: 2012-01-18

Seroquel
    Dosage: 25 mg, 1 in 1 d
    Administration route: Oral
    Indication: Psychiatric Symptom
    Start date: 2012-06-21
    End date: 2012-06-23

Symmetrel
    Dosage: 50 mg, 4 in 1 d
    Administration route: Oral
    Indication: Parkinson's Disease
    End date: 2012-06-19

Zyprexa
    Dosage: 5 mg, 1 in 1 d
    Administration route: Oral
    Indication: Psychiatric Symptom
    Start date: 2012-06-23

Other drugs received by patient: Rinderon-V



Possible Cabergoline side effects in 51 year old male

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-07-16

Patient: 51 year old male

Reactions: Cardiac Valve Sclerosis

Drug(s) suspected as cause:
Cabergoline
    Dosage: 4 mg/day

Cabergoline
    Dosage: 26 mg/day



Possible Cabergoline side effects in 68 year old female

Reported by a physician from Japan on 2012-07-16

Patient: 68 year old female, weighing 42.2 kg (92.8 pounds)

Reactions: Back Pain, Secondary Adrenocortical Insufficiency, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cabergoline
    Dosage: 0.25 mg, weekly
    Administration route: Oral
    Indication: Pituitary-Dependent Cushing's Syndrome
    Start date: 2011-03-10
    End date: 2011-01-01

Cabergoline
    Dosage: 2 mg, weekly
    Administration route: Oral
    Start date: 2011-06-08



Possible Cabergoline side effects in 53 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-13

Patient: 53 year old male

Reactions: Blepharospasm, Psychiatric Symptom, Atrioventricular Block Complete

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Alprazolam
    Dosage: 0.4 mg, 2 in 1 d
    Administration route: Oral
    Indication: Anxiety Disorder

Cabergoline
    Dosage: 1 mg, 1 in 1 d
    Administration route: Oral
    Indication: Parkinson's Disease
    End date: 2012-06-19

Comtan
    Dosage: 100 mg, 1 in 1 d
    Administration route: Oral
    Indication: Parkinson's Disease

Donepezil HCL
    Dosage: 5 mg, 1 in 1 d
    Administration route: Oral
    Start date: 2011-07-05
    End date: 2012-06-21

Donepezil HCL
    Dosage: blinded therapy (3mg or placebo) (1 in 1 d)
    Administration route: Oral
    Indication: Parkinson's Disease
    Start date: 2011-06-23
    End date: 2011-07-04

Dopacol
    Dosage: 87.5 mg, 6 in 1 d
    Administration route: Oral
    Indication: Parkinson's Disease
    Start date: 2011-07-20

Pramipexole Dihydrochloride
    Dosage: 0.25 mg, 1 in 1 d
    Administration route: Oral
    Start date: 2012-01-18

Pramipexole Dihydrochloride
    Dosage: 1 mg, 2 in 1 d
    Administration route: Oral
    Indication: Parkinson's Disease

Seroquel
    Dosage: 25 mg, 1 in 1 d
    Administration route: Oral
    Indication: Psychiatric Symptom
    Start date: 2012-06-21
    End date: 2012-06-23

Symmetrel
    Dosage: 50 mg, 4 in 1 d
    Administration route: Oral
    Indication: Parkinson's Disease
    End date: 2012-06-19

Zyprexa
    Dosage: 5 mg, 1 in 1 d
    Administration route: Oral
    Indication: Psychiatric Symptom
    Start date: 2012-06-23

Other drugs received by patient: Rinderon-V



Possible Cabergoline side effects in 53 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-11

Patient: 53 year old male

Reactions: Blepharospasm, Atrioventricular Block Complete, Psychiatric Symptom

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cabergoline
    Dosage: 1 mg, 1 in 1 d
    Administration route: Oral
    Indication: Parkinson's Disease
    End date: 2012-06-19

Comtan
    Dosage: 100 mg, 1 in 1 d
    Administration route: Oral
    Indication: Parkinson's Disease

Donepezil HCL
    Dosage: blinded therapy (3mg or placebo) (1 in 1 d)
    Administration route: Oral
    Indication: Parkinson's Disease
    Start date: 2011-06-23
    End date: 2011-07-04

Donepezil HCL
    Dosage: 5 mg, 1 in 1 d
    Administration route: Oral
    Start date: 2011-07-05
    End date: 2012-06-21

Dopacol
    Dosage: 87.5 mg, 6 in 1 d
    Administration route: Oral
    Indication: Parkinson's Disease
    Start date: 2011-07-20

Pramipexole Dihydrochloride
    Dosage: 0.25 mg, 1 in 1 d
    Administration route: Oral
    Start date: 2012-01-18

Pramipexole Dihydrochloride
    Dosage: 1 mg, 2 in 1 d
    Administration route: Oral
    Indication: Parkinson's Disease

Seroquel
    Dosage: 25 mg, 1 in 1 d
    Administration route: Oral
    Indication: Psychiatric Symptom
    Start date: 2012-06-21
    End date: 2012-06-23

Symmetrel
    Dosage: 50 mg, 4 in 1 d
    Administration route: Oral
    Indication: Parkinson's Disease
    End date: 2012-06-19

Zyprexa
    Dosage: 5 mg, 1 in 1 d
    Administration route: Oral
    Indication: Psychiatric Symptom
    Start date: 2012-06-23

Other drugs received by patient: Alprazolam; Rinderon-V



Possible Cabergoline side effects in

Reported by a consumer/non-health professional from Belgium on 2012-07-11

Patient:

Reactions: Congenital Absence of Vertebra, Maternal Exposure Timing Unspecified

Drug(s) suspected as cause:
Cabergoline



Possible Cabergoline side effects in 53 year old male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-10

Patient: 53 year old male

Reactions: Blepharospasm, Atrioventricular Block Complete, Psychiatric Symptom

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cabergoline
    Dosage: 1 mg, 1 in 1 d
    Administration route: Oral
    Indication: Parkinson's Disease
    End date: 2012-06-19

Carbidopa + Levodopa
    Dosage: 87.5 mg, 6 in 1 d
    Administration route: Oral
    Indication: Parkinson's Disease
    Start date: 2011-07-20

Comtan
    Dosage: 100 mg, 1 in 1 d
    Administration route: Oral
    Indication: Parkinson's Disease

Donepezil HCL
    Dosage: blinded therapy (3mg or placebo) (1 in 1 d)
    Administration route: Oral
    Indication: Parkinson's Disease
    Start date: 2011-06-23
    End date: 2011-07-04

Donepezil HCL
    Dosage: 5 mg, 1 in 1 d
    Administration route: Oral
    Start date: 2011-07-05
    End date: 2012-06-21

Pramipexole Dihydrochloride
    Dosage: 0.25 mg, 1 in 1 d
    Administration route: Oral
    Start date: 2012-01-18

Pramipexole Dihydrochloride
    Dosage: 1 mg, 2 in 1 d
    Administration route: Oral
    Indication: Parkinson's Disease

Seroquel
    Dosage: 25 mg, 1 in 1 d
    Administration route: Oral
    Indication: Psychiatric Symptom
    Start date: 2012-06-21
    End date: 2012-06-23

Symmetrel
    Dosage: 50 mg, 4 in 1 d
    Administration route: Oral
    Indication: Parkinson's Disease
    End date: 2012-06-19

Zyprexa
    Dosage: 5 mg, 1 in 1 d
    Administration route: Oral
    Indication: Psychiatric Symptom
    Start date: 2012-06-23

Other drugs received by patient: Rinderon-V; Alprazolam



Possible Cabergoline side effects in female

Reported by a physician from United States on 2012-07-03

Patient: female

Reactions: Insulin-Like Growth Factor Decreased

Drug(s) suspected as cause:
Cabergoline



Possible Cabergoline side effects in 77 year old male

Reported by a pharmacist from Japan on 2012-06-29

Patient: 77 year old male

Reactions: NO Adverse Event

Drug(s) suspected as cause:
Cabergoline



Possible Cabergoline side effects in 30 year old female

Reported by a health professional (non-physician/pharmacist) from Poland on 2012-06-26

Patient: 30 year old female

Reactions: Menstrual Disorder, Galactorrhoea, Prolactinoma, Drug Interaction, Neoplasm Progression

Drug(s) suspected as cause:
Cabergoline
    Dosage: 0.25 mg, twice weekly

Cabergoline
    Dosage: 2 mg, twice weekly

Other drugs received by patient possibly interacting with the suspect drug:
Bromocriptine Mesylate
    Dosage: 7.5 mg, daily

Bromocriptine Mesylate
    Dosage: 20 mg, daily

Bromocriptine Mesylate
    Dosage: 15 mg, daily

Oxcarbazepine
    Dosage: 600 mg daily
    Indication: Convulsion

Oxcarbazepine
    Dosage: 1200 mg daily

Other drugs received by patient: Quinagolide; Quinagolide



Possible Cabergoline side effects in 30 year old female

Reported by a health professional (non-physician/pharmacist) from Poland on 2012-06-26

Patient: 30 year old female

Reactions: Galactorrhoea, Menstrual Disorder, Prolactinoma, Neoplasm Progression, Drug Interaction

Drug(s) suspected as cause:
Cabergoline
    Dosage: 0.25 mg, twice weekly

Cabergoline
    Dosage: 2 mg, twice weekly

Other drugs received by patient possibly interacting with the suspect drug:
Bromocriptine Mesylate
    Dosage: 7.5 mg, daily

Bromocriptine Mesylate
    Dosage: 15 mg, daily

Bromocriptine Mesylate
    Dosage: 20 mg, daily

Oxcarbazepine
    Dosage: 1200 mg daily

Oxcarbazepine
    Dosage: 600 mg daily
    Indication: Convulsion

Other drugs received by patient: Quinagolide; Quinagolide



Possible Cabergoline side effects in 45 year old female

Reported by a physician from United States on 2012-06-26

Patient: 45 year old female

Reactions: Mania

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cabergoline



Possible Cabergoline side effects in 77 year old male

Reported by a pharmacist from Japan on 2012-06-26

Patient: 77 year old male

Reactions: Convulsion

Drug(s) suspected as cause:
Cabergoline



Possible Cabergoline side effects in 55 year old male

Reported by a physician from Finland on 2012-06-26

Patient: 55 year old male

Reactions: Therapeutic Response Unexpected, Impulsive Behaviour

Drug(s) suspected as cause:
Cabergoline
    Dosage: 1-2 mg, daily
    Indication: Parkinson's Disease
    Start date: 2002-01-01

Carbidopa + Levodopa
    Dosage: 100/25-200/50 mg, daily
    Indication: Parkinson's Disease
    Start date: 2004-01-01

Selegiline
    Dosage: 5 mg, daily
    Indication: Parkinson's Disease
    Start date: 2001-01-01



Possible Cabergoline side effects in 92 year old female

Reported by a pharmacist from Japan on 2012-06-15

Patient: 92 year old female

Reactions: Choking

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cabergoline



Possible Cabergoline side effects in 69 year old male

Reported by a pharmacist from Japan on 2012-05-24

Patient: 69 year old male

Reactions: Purpura

Drug(s) suspected as cause:
Cabergoline



Possible Cabergoline side effects in 56 year old male

Reported by a physician from Spain on 2012-05-21

Patient: 56 year old male

Reactions: Pneumocephalus

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Cabergoline



Possible Cabergoline side effects in

Reported by a individual with unspecified qualification from Germany on 2012-05-21

Patient:

Reactions: Mitral Valve Sclerosis, Mitral Valve Prolapse, Mitral Valve Incompetence, Aortic Valve Sclerosis, Tricuspid Valve Sclerosis, Intentional Drug Misuse, Aortic Valve Incompetence

Drug(s) suspected as cause:
Cabergoline
    Dosage: 4 mg, / day
    Indication: Parkinson's Disease

Cabergoline
    Dosage: 26 mg, / day



Possible Cabergoline side effects in 45 year old female

Reported by a consumer/non-health professional from Finland on 2012-05-21

Patient: 45 year old female

Reactions: Bone Loss, Arthralgia, Chest Pain, Insomnia, Feeling Abnormal

Drug(s) suspected as cause:
Cabergoline



Possible Cabergoline side effects in 69 year old male

Reported by a pharmacist from Japan on 2012-05-21

Patient: 69 year old male

Reactions: Haemorrhage, Purpura

Drug(s) suspected as cause:
Cabergoline

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017